Regulus Therapeutics
RGLS
#8770
Rank
โ‚น8.12 B
Marketcap
โ‚น124.04
Share price
-0.68%
Change (1 day)
12.81%
Change (1 year)

Regulus Therapeutics (RGLS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚น0.50 Billion

According to Regulus Therapeutics's latest financial reports the company's total liabilities are โ‚น0.50 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regulus Therapeutics - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚น1.11 B10.59%
2021-12-31โ‚น1.00 B18.63%
2020-12-31โ‚น0.84 B-46.19%
2019-12-31โ‚น1.57 B-33.38%
2018-12-31โ‚น2.36 B-13.15%
2017-12-31โ‚น2.71 B-10.24%
2016-12-31โ‚น3.02 B168.11%
2015-12-31โ‚น1.13 B-54.82%
2014-12-31โ‚น2.50 B36.74%
2013-12-31โ‚น1.82 B-19.35%
2012-12-31โ‚น2.26 B-49.18%
2011-12-31โ‚น4.46 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น5.036 T 1,005,022.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น5.133 T 1,024,549.71%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น1.008 T 201,218.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.462 T 1,090,199.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น352.09 B 70,170.97%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.84 B 1,067.46%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น6.452 T 1,287,707.34%๐Ÿ‡บ๐Ÿ‡ธ USA